Paul Andrea has filed 7 insider transactions across 1 company since February 2024.
Most recent transaction: a grant/award of 934041 shares of Zentalis Pharmaceuticals, Inc. ($ZNTL) on February 03, 2025.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 3, 2025 | Zentalis Pharmaceuticals, Inc. | $ZNTL | Paul Andrea | Chief Legal Officer | A | Common Stock | 934041 | $0.00 | 1,084,014.0000 | 0 | 622.81% | 0.00% |
| Feb. 3, 2025 | Zentalis Pharmaceuticals, Inc. | $ZNTL | Paul Andrea | Chief Legal Officer | S | Common Stock | 13230 | $1.71 | 1,070,784.0000 | 0 | 1.22% | 0.00% |
| Feb. 3, 2025 | Zentalis Pharmaceuticals, Inc. | $ZNTL | Paul Andrea | Chief Legal Officer | A | Stock Option (Right to Buy) | 124714 | $0.00 | 124,714.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2024 | Zentalis Pharmaceuticals, Inc. | $ZNTL | Paul Andrea | Chief Legal Officer | A | Common Stock | 112500 | $0.00 | 153,283.0000 | 0 | 275.85% | 0.00% |
| Feb. 2, 2024 | Zentalis Pharmaceuticals, Inc. | $ZNTL | Paul Andrea | Chief Legal Officer | S | Common Stock | 3310 | $11.54 | 149,973.0000 | 0 | 2.16% | 0.00% |
| Feb. 1, 2024 | Zentalis Pharmaceuticals, Inc. | $ZNTL | Paul Andrea | Chief Legal Officer | A | Stock Option (Right to Buy) | 112500 | $0.00 | 112,500.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2024 | Zentalis Pharmaceuticals, Inc. | $ZNTL | Paul Andrea | Chief Legal Officer | A | Stock Option (Right to Buy) | 90000 | $0.00 | 90,000.0000 | 0 | 9999.99% | 0.00% |